Mutation in st6galnac5 identified in family with coronary artery disease

Scientific Reports

Volumn 4, Issue , 2014, Pages

  InanlooRahatloo, Kolsoum ^a,b   Parsa, Amir Farhang Zand ^c   Huse, Klaus ^b   Rasooli, Paniz ^a   Davaran, Saeid ^d   Platzer, Matthias ^b   Kramer, Marcel ^e   Fan, Jian Bing ^f   Turk, Casey ^f   Amini, Sasan ^f   Steemers, Frank ^f   Gunderson, Kevin ^f   Ronaghi, Mostafa ^f   Elahi, Elahe ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e JENA UNIVERSITY HOSPITAL   (Germany)

^f ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN SPECIFIC GD1ALPHA SYNTHASE, ST6GALNAC V; BRAIN-SPECIFIC GD1ALPHA SYNTHASE, ST6GALNAC V; SIALYLTRANSFERASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; PEDIGREE;

ADULT; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; SIALYLTRANSFERASES;

EID: 84891769587     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03595     Document Type: Article

References (57)

1. Wang, Q. Molecular genetics of coronary artery disease. Curr. Opin. Cardiol. 20,182-188 (2005) (Pubitemid 40704874)
2. Lusis, A. J., Mar, R. & Pajukanta, P. Genetics of atherosclerosis. Annu. Rev. Genomics. Hum. Genet. 5,189-218 (2004)
3. Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. New. Engl. J. Med. 330, 1041-1046 (1994) (Pubitemid 24106561)
4. Nora, J. J., Lortsher, R. H., Spangler, R. D., Nora, A. H. & Kimberling, W. J. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation. 61, 503-508 (1980) (Pubitemid 10179693)
5. Schildkraut, J. M., Myers, R. H., Cupples, L. A., Kiely, D. K. & Kannel, W. B. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am. J. Cardiol. 64, 555-559 (1989) (Pubitemid 19230219)
6. Hegele, R. A. Plasma lipoproteins: genetic influences and clinical implications. Nat. Rev. Genet. 10, 109-121 (2009)
7. Ghazalpour, A., Wang, X., Lusis, A. J. & Mehrabian, M. Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice. Genetics. 173, 943-951 (2006) (Pubitemid 43945909)
8. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011)
9. Holdt, L. M. & Teupser, D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler. Thromb. Vasc. Biol. 32, 196-206 (2012)
10. Wang, L., Fan, C., Topol, S. E., Topol, E. J. &Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 302, 1578-1581 (2003) (Pubitemid 37475704)
11. Mani, A. et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 315, 1278-1282 (2007) (Pubitemid 46364265)
12. Fujino, T. et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc. Natl Acad Sci USA. 100, 229-234 (2003) (Pubitemid 36078057)
13. Weng, L. et al. Lack of MEF2A mutations in coronary artery disease. J. Clin. Invest. 115, 1016-1020 (2005) (Pubitemid 40489406)
14. Guella, I. et al. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease. Circ Cardiovasc Genet 2, 165-172 (2009)
15. Liu, Y. et al. Variants in Exon 11 of MEF2A Gene and Coronary Artery Disease: Evidence from a Case-Control Study, Systematic Review, and Meta-Analysis. PLoS ONE, 7, 1 (2012)
16. Altshuler, D. & Hirschhorn, J. N. MEF2A sequence variants and coronary artery disease: a change of heart? J. Clin. Invest. 115, 831-833 (2005) (Pubitemid 40489384)
17. Barth, A. S. et al. Functional profiling of human atrial and ventricular gene expression. Eur. J. Phy. 450, 201-208 (2005) (Pubitemid 40966573)
18. Gudmundsson, G. et al. Localization of a Gene for Peripheral Arterial Occlusive Disease to Chromosome 1p31. Am. J. Hum. Genet. 70, 586-592 (2002) (Pubitemid 34177914)
19. Allayee, H. et al. Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia. Circ. Res. 90, 926-931 (2002) (Pubitemid 34633886)
20. Seidelmann, S. B., Li, L., Shen, G. Q., Topol, E. J. & Wang, Q. Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI. J. Lipid. Res. 49, 1034-1038 (2008)
21. Harduin-Lepers, A. Comprehensive Analysis of Sialyltransferases in Vertebrate Genomes. Glycobiology. Insights. 2, 29-61 (2010)
22. Audry, M. et al. Current trends in the structure-activity relationships of sialyltransferases. Glycobiology 21, 716-726 (2011)
23. Data, A. K., Chammas, R. & Paulson, J. C. Conserved cysteines in the sialyltransferase sialylmotifs form an essential disulfide bond. J. Biol. Chem. 276, 15200-15207 (2001)
24. Ferre, F. & Clote, P. DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucleic Acids Res. Jul 1; 34(Web Server issue): W182-5 (2006) (Pubitemid 44529760)
25. Wu, Z. L., Ethen, C. M., Prather, B., Machacek, M. & Jiang, W. Universal phosphatase-coupled glycosyltransferase assay. Glycobiology. 21, 727-733 (2011)
26. Broquet, P., Baubichon-Cortay, H., George, P. & Louisot, P. Glycoprotein sialyltransferases in eucaryotic cells. Int. J. Biochem. 23, 385-389 (1991)
27. Appeddu, P. A. & Shur, B. D. Molecular analysis of cell surface b-1, 4- galactosyltransferase function during cell migration. Proc. Natl. Acad. Sci. USA. 91, 2095-2099 (1994) (Pubitemid 24092049)
28. Kaufmann, M. et al. Identification of an a2, 6-sialyltransferase induced early after lymphocyte activation. Int. Immunol. 11, 731-738 (1999) (Pubitemid 29237764)
29. Gracheva, E. V. et al. Sialyltransferase activity of human plasma and aortic intima is enhanced in Atherosclerosis. Biochem. Biophys. Acta. 1586, 123-128 (2002) (Pubitemid 34066623)
30. Okajima, T. et al. Molecular cloning of brain-specific GD1alpha synthase (ST6GalNAc V) containing CAG/Glutamine repeats. J. Biol. Chem. 274, 30557-30562 (1999)
31. Schauer, R. Chemistry, metabolism, and biological functions of sialic acids. Adv. Carbohydr. Chem. Biochem. 40, 131-234 (1982)
32. Varki, A. Sialic acids as ligands in recognition phenomena. FASEB. J. 11, 248-255 (1997) (Pubitemid 27118325)
33. Scialla, S. J., Speckart, S. F., Haut, M. J. & Kimball, D. B. Alterations in platelet surface sialyltransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis. Cancer. Res. 39, 2031-2035 (1979) (Pubitemid 9184995)
34. Wu, K. K. & Ku, C. S. L. Stimulation of platelet surface sialyltransferase activity by platelet aggregating agents. Thromb. Res. 13, 183-192 (1978) (Pubitemid 9043338)
35. Hagg, S. et al. Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study. PloS. Genet. 5, e1000754; DOI:10.1371/pgen1000754 (2009)
36. Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature. 459, 1005-1009 (2009)
37. Gopaul, K. P.&Crook, M. A. Sialic acid:Anovel marker of cardiovascular disease? Clin. Biochem. 39, 667-681 (2006) (Pubitemid 44055927)
38. Succari, M., Foglietti, M. J. & Percheron, F. Perchlorosoluble glycoproteins and myocardial infarct: modifications of the carbohydrate moiety. Pathol Biol. 30, 151-154 (1982) (Pubitemid 12139807)
39. Hrncir, Z., Pidrman, V., Tichy, M. & Hamet, A. Serum sialic acid in acute myocardial infarction in a dynamic follow up. Vnitr. Lek. 21, 436-439 (1975)
40. Lindberg, G., Råstam, L., Gullberg, B. & Eklund, G. A. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54385 men and women during 20.5 years followup. Int. J. Epidemiol. 21, 253-257 (1992)
41. Råstam, L. et al. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. Int. J. Epidemiol. 25, 953-958 (1996) (Pubitemid 26348672)
42. Knuiman, M. W., Watts, G. F. & Divitini, M. L. Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia. Ann. Epidemiol. 14, 627-632 (2004) (Pubitemid 39233622)
43. Watts, G. F., Crook, M. A.,Haq, S. &Mandalia, S. Serum sialic acid as an indicator of change in coronary artery disease. Metabolis. 44, 147-148 (1995)
44. Tsuchida, A. et al. Synthesis of disialyl Lewis a (Lea) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of aseries gangliosides. J. Biol. Chem. 278, 22787-22794 (2003) (Pubitemid 36830340)
45. Saade, S. et al. Large scale association analysis identifies three susceptibility loci for coronary artery disease. PLoS ONE. 6, e29427. doi:10.1371/journal.pone.0029427 (2011)
46. Lindberg, G. Resialylation of sialic acid deficit vascular endothelium, circulating cells and macromolecules may counteract the development of atherosclerosis: A hypothesis. Atherosclerosis. 192, 243-245 (2007)
47. Göroög P. & Born, G. V. Uneven distribution of sialic acids on the luminal surface of aortic endothelium. Br. J. Exp. Pathol. 64, 418-424 (1983) (Pubitemid 13001136)
48. Göroög P. & Born, G. V. R. Increase uptake of circulating LDL and fibrinogen by arterial walls after removal of sialic acids from their endothelial surface. Br. J. Exp. Path. 63, 447-451 (1982) (Pubitemid 12064318)
49. Tertov, V. V., Sobenin, I. A. & Orekhov, A. N. Characterisation of desialylated low-density lipoprotein which cause intracellular lipid accumulation. Int. J. Tissue. Reac. 14, 155-162 (1992) (Pubitemid 23003845)
50. Ruelland, A. et al. LDL sialic acid content in type 2 diabetic patients. Clinica. Chimica. Acta. 259, 191-193 (1997) (Pubitemid 127738661)
51. Mandic, R., Opper, C., Krappe, J. & Wesemann, W. Platelet sialic acid as a potential pathogenic factor in coronary heart disease. Thromb. Res. 106, 137-141 (2002) (Pubitemid 35245238)
52. Kario, K. & Matsuo, T. Relation between sialic acid concentrations and the haemostatic system in the elderly. BMJ. 306, 1650-1651 (1993) (Pubitemid 23168397)
53. Crook, M. A., Tutt, P., Simpson, H. & Pickup, J. C. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin. Chim. Acta. 219, 131-138 (1993) (Pubitemid 23332668)
54. Paoletti, R.,Gotto, A. M.&Hajjar, D. P. Atherosclerosis: Evolving vascular biology and clinical implications, Inflammation in atherosclerosis and implications for therapy. Circulation. 109, (Suppl III):III20-6; DOI:10.1161/01.CIR.0000131514.71167.2e (2004)
55. The CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nature Genetic. 45, 25-33 (2013)
56. Rosen, S. D. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22, 129-156 (2004) (Pubitemid 38680420)
57. Abecasis, G. R., Cherny, S. S., Cookson, W. O. & Cardon, L. R. Merlin rapid analysis of dense genetic maps using sparse gene flow trees.Nat. Genet. 30, 97-101 (2002)